Delivery Order SPE2DB20D2104-SPE2DB25FMGUX

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $9,775.26 and an ultimate completion date of July 10, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,751.89 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 1, 2024. The contract has a firm fixed price and an ultimate completion date of August 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $20,067.99 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024, with a completion date of November 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S medication to the Defense Logistics Agency (DLA), a defense agency. The $23,678.05 firm fixed-price contract was awarded on March 11, 2024 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a completion date of March 12, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,537.26 and an ultimate completion date of April 1, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S medication to the Defense Logistics Agency (DLA). The $13,507.33 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 31, 2024. The contract has an ultimate completion date of January 2, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $17,087.62 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 6, 2024. The contract is not designated as a set-aside and was awarded as...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,770.01 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The $9,659.15 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, which serves as a...
The federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,382.76 and is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract is a Firm Fixed Price arrangement, with an ultimate completion date of August 15, 2024. This award is associated with an Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMGUX
    Delivery Order

This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $16,397.78, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 29, 2025.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/21/25, 10:11 AM